Frontiers in Anti-infective Agents

Author(s): Islam M. Ghazi*, Diaa Alrahmany and Wasim S. El Nekidy

DOI: 10.2174/9789811461835120030008

Molecular Basis of Resistance III

Pp: 149-171 (23)

Buy Chapters

* (Excluding Mailing and Handling)

  • * (Excluding Mailing and Handling)

Abstract

SHS investigation development is considered from the geographical and historical viewpoint. 3 stages are described. Within Stage 1 the work was carried out in the Department of the Institute of Chemical Physics in Chernogolovka where the scientific discovery had been made. At Stage 2 the interest to SHS arose in different cities and towns of the former USSR. Within Stage 3 SHS entered the international scene. Now SHS processes and products are being studied in more than 50 countries.

Abstract

The rapid evolvement of fungal resistance to therapeutic agents merits a thorough understanding of the molecular and genetic basis of this deleterious phenomenon. Accumulating efforts expanded our understanding of potential resistance mechanisms that fungi utilize to combat Antifungal therapy like modification of biological targets, gene overexpression, efflux pumps, and regulation of transcriptional factors in response to stress and biofilm formation. The tremendous genomic plasticity of fungi added to the involvement of a multitude of molecular resistance determinants and the paucity of novel targets for therapy mandate utilizing innovative approaches to therapy in parallel to relentless research to develop effective antifungal agents surmounting rapidly increasing resistance. In this chapter, we illustrate a myriad of resistance mechanisms along with other relevant topics like the mechanism of action of antifungal classes, laboratory methods for detecting resistance, clinical susceptibility testing and future insights.

Recommended Chapters

We recommend

Favorable 70-S: Investigation Branching Arrow

Authors:Bentham Science Books